These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 98780)

  • 61. Normalization by antipsychotic drugs of biochemically induced abnormal behavior in rats.
    Ahlenius S; Engel J
    Psychopharmacology (Berl); 1976 Aug; 49(1):63-8. PubMed ID: 822449
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Noradrenergic influence on the prepulse inhibition of acoustic startle.
    Saitoh K; Shaw S; Tilson HA
    Toxicol Lett; 1986 Dec; 34(2-3):209-16. PubMed ID: 3798479
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of pimozide on the acquisition, maintenance, and extinction of an amphetamine-induced taste aversion.
    Grupp LA
    Psychopharmacology (Berl); 1977 Aug; 53(3):235-42. PubMed ID: 408851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potentiation of D- and L-amphetamine effects on copulatory behavior in female rats by treatment with alpha-adrenoreceptor blocking drugs.
    Michanek A
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):241-56. PubMed ID: 39533
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine.
    Michanek A; Meyerson BJ
    Pharmacol Biochem Behav; 1982 Jun; 16(6):875-9. PubMed ID: 7202216
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.
    Brauer LH; De Wit H
    Pharmacol Biochem Behav; 1997 Feb; 56(2):265-72. PubMed ID: 9050084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of lysergic acid diethylamide (LSD) on temporal recovery (pre-pulse inhibition) of the acoustic startle response in the rat.
    Davis M; Sheard MH
    Pharmacol Biochem Behav; 1975; 3(5):861-8. PubMed ID: 1208627
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Attenuation by pimozide of the suppressant effect of d-amphetamine on operant behaviour.
    Morley MJ; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1987; 91(2):239-43. PubMed ID: 3107040
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains.
    Swerdlow NR; Shoemaker JM; Platten A; Pitcher L; Goins J; Crain S
    Pharmacol Biochem Behav; 2003 Apr; 75(1):191-7. PubMed ID: 12759127
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Involvement of norepinephrine in startle arousal after acute and chronic d-amphetamine administration.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1978 Dec; 59(3):285-92. PubMed ID: 104332
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine.
    Sanberg PR
    Physiol Behav; 1989 Aug; 46(2):199-202. PubMed ID: 2602459
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats.
    Yokel RA; Wise RA
    Psychopharmacology (Berl); 1976 Aug; 48(3):311-8. PubMed ID: 823588
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prepulse inhibition of the acoustic startle reflex using visual and auditory prepulses: disruption by apomorphine.
    Campeau S; Davis M
    Psychopharmacology (Berl); 1995 Feb; 117(3):267-74. PubMed ID: 7770602
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of apomorphine and of pimozide on renin secretion in the anaesthetized dog.
    Imbs JL; Schmidt M; Velly J; Schwartz J
    Eur J Pharmacol; 1976 Jul; 38(1):175-8. PubMed ID: 954826
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.
    Dorris RL; Shore PA
    Biochem Pharmacol; 1974 Feb; 23(4):867-72. PubMed ID: 4150986
    [No Abstract]   [Full Text] [Related]  

  • 77. Avoidance learning and mechanism of the protective effect of apomorphine against hypoxia.
    Boismare F; Saligaut C; Moore N; Raoult JP
    Aviat Space Environ Med; 1981 May; 52(5):299-303. PubMed ID: 7247902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nigral dopaminergic neurons: differential sensitivity to apomorphine following long-term treatment with low and high doses of amphetamine.
    Kamata K; Rebec GV
    Brain Res; 1984 Oct; 321(1):147-50. PubMed ID: 6498510
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Does tolerance develop to low doses of d- and l-amphetamine on locomotor activity in rats?
    Weston PF; Overstreet DH
    Pharmacol Biochem Behav; 1976 Dec; 5(6):645-9. PubMed ID: 1023233
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.